ATE394492T1 - Verfahren zur oligomerisation von peptiden - Google Patents

Verfahren zur oligomerisation von peptiden

Info

Publication number
ATE394492T1
ATE394492T1 AT97948802T AT97948802T ATE394492T1 AT E394492 T1 ATE394492 T1 AT E394492T1 AT 97948802 T AT97948802 T AT 97948802T AT 97948802 T AT97948802 T AT 97948802T AT E394492 T1 ATE394492 T1 AT E394492T1
Authority
AT
Austria
Prior art keywords
oligomerization
peptides
oligomer
oligomerizing
domain
Prior art date
Application number
AT97948802T
Other languages
English (en)
Inventor
Alexey Terskikh
Reto Crameri
Jean-Pierre Mach
Doussal Jean-Marc Le
Andrey Kajava
Original Assignee
Univ Lausanne
Swiss Inst For Allergy And Ast
Inst Suisse De Rech S Experime
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Lausanne, Swiss Inst For Allergy And Ast, Inst Suisse De Rech S Experime, Novartis Pharma Gmbh filed Critical Univ Lausanne
Application granted granted Critical
Publication of ATE394492T1 publication Critical patent/ATE394492T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT97948802T 1996-10-28 1997-10-24 Verfahren zur oligomerisation von peptiden ATE394492T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810719 1996-10-28

Publications (1)

Publication Number Publication Date
ATE394492T1 true ATE394492T1 (de) 2008-05-15

Family

ID=8225734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948802T ATE394492T1 (de) 1996-10-28 1997-10-24 Verfahren zur oligomerisation von peptiden

Country Status (7)

Country Link
US (1) US20100105876A1 (de)
EP (1) EP0938571B8 (de)
AT (1) ATE394492T1 (de)
AU (1) AU6909298A (de)
DE (1) DE69738670D1 (de)
ES (1) ES2309999T3 (de)
WO (1) WO1998018943A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160088A (en) * 1998-07-29 2000-12-12 Sloan-Kettering Institute For Cancer KDEL receptor inhibitors
WO2000044908A2 (en) * 1999-02-01 2000-08-03 Beth Israel Deaconess Medical Center Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
JP2002544285A (ja) * 1999-05-14 2002-12-24 メディカル リサーチ カウンシル オリゴマーシャペロンタンパク質
AU4770300A (en) * 1999-05-14 2000-12-05 Medical Research Council Protein scaffold and its use to multimerise monomeric polypeptides
US20040115180A1 (en) * 2001-03-06 2004-06-17 Mustapha Abdelouahed Carrier chimeric proteins targeted carrier chimeric proteins and preparation thereof
WO2003046560A2 (en) * 2001-11-30 2003-06-05 National Research Council Of Canada Self-assembly molecules
AU2004226162A1 (en) * 2003-04-04 2004-10-14 Universite De Lausanne Peptabody for cancer treatment
GB2408507B (en) * 2003-10-06 2005-12-14 Proimmune Ltd Chimeric MHC protein and oligomer thereof for specific targeting
GB2409456B (en) * 2003-10-30 2006-01-04 Proimmune Ltd Oligomeric receptor ligand pair member complexes
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
JP4819697B2 (ja) 2003-12-23 2011-11-24 ヴィアサイト，インコーポレイテッド 胚体内胚葉
US8586357B2 (en) 2003-12-23 2013-11-19 Viacyte, Inc. Markers of definitive endoderm
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
JP5102030B2 (ja) 2004-08-13 2012-12-19 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド ヒト胚性幹細胞における自己再生および分化のための組成物および方法
WO2007127454A2 (en) 2006-04-28 2007-11-08 Cythera, Inc. Hepatocyte lineage cells
US7695963B2 (en) 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
TWI489993B (zh) 2007-10-12 2015-07-01 Novartis Ag 骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
PY09026846A (es) 2008-08-05 2015-09-01 Novartis Ag Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5
KR20120093754A (ko) 2009-03-10 2012-08-23 메드 디스커버리 에스에이 세린 프로테아제 저해제의 호중구감소증 치료에서의 용도
WO2010102518A1 (zh) * 2009-03-13 2010-09-16 北京表源生物技术有限公司 一种融合蛋白多聚体
CA2993053A1 (en) 2009-04-27 2010-11-04 Novartis Ag Antagonistic activin receptor iib (actriib) antibodies for increasing muscle growth
WO2011029823A1 (en) 2009-09-09 2011-03-17 Novartis Ag Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
DK2726099T3 (en) 2011-07-01 2018-11-05 Novartis Ag Method of treating metabolic disorders
WO2014089111A1 (en) 2012-12-05 2014-06-12 Novartis Ag Compositions and methods for antibodies targeting epo
CA2918300A1 (en) 2013-08-14 2015-02-19 Novartis Ag Methods of treating sporadic inclusion body myositis
TW201622746A (zh) 2014-04-24 2016-07-01 諾華公司 改善或加速髖部骨折術後身體復原之方法
SI3600415T1 (sl) 2017-03-24 2026-01-30 Novartis Ag Protitelo proti aktivinskemu receptorju tipa ii za uporabo pri zdravljenju srčnega popuščanja
EP3601573A4 (de) * 2017-03-29 2020-12-23 Sunnybrook Research Institute Manipulierte t-zell-modulierende moleküle und verfahren zur verwendung davon
EP3704150A1 (de) * 2017-11-01 2020-09-09 F. Hoffmann-La Roche AG Compbody ein multivalentes zielbindemittel
CN115232205A (zh) * 2022-08-03 2022-10-25 南京京达生物技术有限公司 一种鼠源IgM亚型单克隆抗体纯化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026985A1 (en) * 1994-04-05 1995-10-12 Board Of Regents, The University Of Texas System Modified receptors that continuously signal
GB9409768D0 (en) * 1994-05-16 1994-07-06 Medical Res Council Trimerising polypeptides
ATE274064T1 (de) * 1995-05-23 2004-09-15 Morphosys Ag Multimere proteine

Also Published As

Publication number Publication date
US20100105876A1 (en) 2010-04-29
EP0938571B1 (de) 2008-05-07
AU6909298A (en) 1998-05-22
WO1998018943A1 (en) 1998-05-07
DE69738670D1 (de) 2008-06-19
EP0938571B8 (de) 2008-07-02
ES2309999T3 (es) 2008-12-16
EP0938571A1 (de) 1999-09-01

Similar Documents

Publication Publication Date Title
DE69738670D1 (de) Verfahren zur oligomerisation von peptiden
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
DK0934526T3 (da) Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål
ATE137245T1 (de) Synthetische peptide zum in vivo nachweis von thrombosen
DK0724456T3 (da) CD40-Antistoffer
DE69735359D1 (de) System zur auswahl von produkten
DE69733650D1 (de) System zur gleichzeitigen durchführung von mehrfachligandenbindungstests
ATE309347T1 (de) Protocadherin-proteine und verwendungen davon
ATE210683T1 (de) Vernetzungsprodukte von aminogruppen-haltigen biopolymeren
IL130036A0 (en) Survivin a protein that inhibits cellular apoptosis and its modulation
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
DE69413904D1 (de) Olefinpolymerisationskatalysatoren und Methoden zur Olefinpolymerisation
ATE197307T1 (de) Neuroaktive peptide
ATE182622T1 (de) Gen des von hippel-lindau (vhl) syndroms und entsprechende cdns und methoden zur detektion von trägern des entsprechenden gens
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
ES2152953T3 (es) Anticuerpos especificos para una proteina hemostatica, su utilizacion para aislar proteinas intactas, compuestos hemostaticos carentes de productos de segmentacion proteolitica de la proteina.
ATE223481T1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
ATE206714T1 (de) Kombinatorisches verfahren zur identifizierung von organometallischen polymerisationskatalysatoren
ATE190318T1 (de) Pcna bindende substanz
DE69631230D1 (de) Kodediskriminierungssystem zur schnellen Ermittlung der Kodeübereinstimmung
SE9803891D0 (sv) Protein Variants
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
ATE171217T1 (de) Methoden zur synthese und reinigung von peptiden
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE59702891D1 (de) Verfahren zur Oligomerisierung von i-Buten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties